1987
DOI: 10.1289/ehp.877564
|View full text |Cite
|
Sign up to set email alerts
|

Possible etiologic mechanisms in chemical carcinogenesis.

Abstract: Some highlights in the development of our knowledge about carcinogens as etiological agents for cancer are reviewed briefly. Advances during the past 20 years relating to metabolic activation with the genesis of reactive metabolites, molecular targets and their interactions with activated carcinogens, oncogenes as molecular targets and the dependence on cell proliferation, all relating to the initiation process, are reviewed. Critical to initiation is the new phenotype in the initiated cell, known only in one … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

1989
1989
2021
2021

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…The preneoplastic phenotype in vivo is usually initially recognised as a focus of autonomously proliferating cells that often exhibit surface antigen or cytosolic enzymatic alterations. The subsequent appearance of neoplasia at the sites of such lesions has been well documented in experimental models in a variety of tissues (Farber, 1987), but it is not clear which factors dictate the eventual development of clinical cancer. The relatively restricted window of carcinogen susceptibility that is evident during or around puberty in both rodents and humans has been postulated to either contain the greatest number of target cells or be a critical period of stem cell regulation (Boice, 2001).…”
Section: A7 Summary and Conclusionmentioning
confidence: 99%
“…The preneoplastic phenotype in vivo is usually initially recognised as a focus of autonomously proliferating cells that often exhibit surface antigen or cytosolic enzymatic alterations. The subsequent appearance of neoplasia at the sites of such lesions has been well documented in experimental models in a variety of tissues (Farber, 1987), but it is not clear which factors dictate the eventual development of clinical cancer. The relatively restricted window of carcinogen susceptibility that is evident during or around puberty in both rodents and humans has been postulated to either contain the greatest number of target cells or be a critical period of stem cell regulation (Boice, 2001).…”
Section: A7 Summary and Conclusionmentioning
confidence: 99%
“…The study of mechanisms of carcinogenesis is a rapidly developing field and is essential for understanding both the role of mutagenicity tests and methods for rational risk assessment in regulatory policy. Both DNA damage and cell proliferation (i.e., promotion) are essential aspects of carcinogenesis, and agents that increase either are carcinogens Farber, 1987;Pitot et al, 19871. The classical chemical promoters such as phenobarbital and tetradecanoyl phorbol acetate would be expected to be, and are in fact, carcinogens in animals when tested thoroughly [Iversen, 19881. In nondividing tissues, such as the liver (a major target site for carcinogens in rodents [Gold et al, 1989a]), mutation is not sufficient for carcinogenesis: Cells are communicating and telling each other not to grow [Trosko, 1988;Trosko and Chang, 1988;Yamasaki et al, 19881.…”
Section: Exogenous Carcinogens and Mechanisms Of Carcinogenesismentioning
confidence: 99%
“…It is important to evaluate risks of synthetic chemicals against the background of the chemicals we encounter from agents causing cell proliferation exhibit thresholds [Farber, 1987;Pitot et al, 19871. Carcinogenesis is a multihit and multistage process. Several mutations appear necessary for carcinogenesis; there are many layers of defense against carcinogens, and most of these defenses are inducible.…”
Section: Nature's Pesticidesmentioning
confidence: 99%
See 2 more Smart Citations